Singapur #10392 (v.1)
Datos básicos
- Notificada en
-
G/MA/QR/N/SGP/7 06/11/2024
- Validez de la versión
-
01/09/2024 -
actual
Versión activa actual v.1
- Miembro informante
- Singapur
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Non-automatic licence for import and export of active ingredient containing psychotropic substances
- Fundamento jurídico nacional
-
Health Products Act, 2007
&
Health Products (Active Ingredients) Regulations 2023
Date of Entry into force: 18 December 2023
- Mecanismo administrativo
-
More information can be found at: https://www.hsa.gov.sg/controlled-drugs-psychotropic-substances.
Administered by HSA.
- Entidades responsables
-
- Versión del SA
-
HS 2022
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Article XX(b) of the GATT - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
UN Convention (1988) on Narcotic Drugs and Psychotropic Substances
Notificada como: United Nations Convention on Psychotropic Substances, 1971 - Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- NAL, NAL-X
Signatura |
---|
NAL
|
NAL-X
|
Líneas arancelarias
13
|
Chapter 13
|
Active ingredients are defined as any substances or compounds that are usable in the manufacture of...
|
|
29
|
Chapter 29
|
Active ingredients are defined as any substances or compounds that are usable in the manufacture of...
|
|
38
|
Chapter 38
|
Active ingredients are defined as any substances or compounds that are usable in the manufacture of...
|
|